Cite
EE320 Cost-Effectiveness of Chimeric Antigen Receptor (CAR) T-Cell Therapies for Blood Cancers: A Systematic Review.
MLA
Patel, N., et al. “EE320 Cost-Effectiveness of Chimeric Antigen Receptor (CAR) T-Cell Therapies for Blood Cancers: A Systematic Review.” Value in Health, vol. 26, no. 6, June 2023, p. S118. EBSCOhost, https://doi.org/10.1016/j.jval.2023.03.621.
APA
Patel, N., Farid, S., & Gomes, M. (2023). EE320 Cost-Effectiveness of Chimeric Antigen Receptor (CAR) T-Cell Therapies for Blood Cancers: A Systematic Review. Value in Health, 26(6), S118. https://doi.org/10.1016/j.jval.2023.03.621
Chicago
Patel, N., S. Farid, and M. Gomes. 2023. “EE320 Cost-Effectiveness of Chimeric Antigen Receptor (CAR) T-Cell Therapies for Blood Cancers: A Systematic Review.” Value in Health 26 (6): S118. doi:10.1016/j.jval.2023.03.621.